Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseHematopoietic Stem Cell TransplantationTransplantation, AutologousBone and BonesTransplantation ConditioningLiver TransplantationTransplantation ChimeraWhole-Body IrradiationGraft SurvivalTissue DonorsLeukemiaHematopoietic Stem CellsTransplantation, IsogeneicAnemia, AplasticKidney TransplantationBusulfanHistocompatibility TestingStem Cell TransplantationHematologic NeoplasmsBone Marrow DiseasesHistocompatibilityBone Marrow PurgingRecurrenceTreatment OutcomeBone Marrow ExaminationGraft RejectionImmunosuppressive AgentsMice, Inbred C57BLBone RemodelingLeukemia, Myeloid, AcuteTransplantation ImmunologyCyclophosphamideHematopoiesisRemission InductionTime FactorsT-LymphocytesBone Marrow NeoplasmsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft vs Tumor EffectHeart TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaPeripheral Blood Stem Cell TransplantationCombined Modality TherapyLymphocyte DepletionAcute DiseaseRadiation ChimeraImmunosuppressionLeukemia, MyeloidMultiple MyelomaGranulocyte Colony-Stimulating FactorSurvival AnalysisLung TransplantationRetrospective StudiesAntigens, CD34Myelodysplastic SyndromesHematopoietic Stem Cell MobilizationBone DensityHepatic Veno-Occlusive DiseaseGraft vs Leukemia EffectLymphoma, Non-HodgkinColony-Forming Units AssayHLA AntigensCyclosporineCells, CulturedFlow CytometryCell DifferentiationBlood CellsLymphocyte TransfusionSurvival RateOrgan TransplantationGraft vs Host ReactionNuclear FamilyBone ResorptionMelphalanCord Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsMice, Inbred BALB CLeukocyte TransfusionDisease-Free SurvivalFollow-Up StudiesChimeraSpleenImmunophenotypingLeukocyte CountCell SeparationCytomegalovirus InfectionsLymphomaMyeloablative AgonistsCell TransplantationHematologic DiseasesAntigens, CDIslets of Langerhans TransplantationAntibodies, MonoclonalSevere Combined ImmunodeficiencyLymphocytesLeukocytes, Mononuclear